[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349654-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349654-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","secreted-protein-circuits-in-the-gastrointestinal-tumour-microenvironment-determinants-of-immunotherapy-response-and-resistance","Secreted protein circuits in the gastrointestinal tumour microenvironment: determinants of immunotherapy response and resistance","","Immune checkpoint blockade has transformed treatment in selected gastrointestinal cancers, but primary resistance, incomplete responses, and acquired resistance remain common. This heterogeneity cannot be explained by tumour-cell genomics alone; extracellular signalling programmes in the tumour microenvironment govern immune recruitment, access, exclusion, suppression, and exhaustion. The tumour secretome, including cytokines, chemokines, growth factors, complement, soluble checkpoint molecules and extracellular-vesicle cargo, regulates immune-state evolution across anatomical and molecular contexts, shaping whether therapies succeed or fail.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/secreted-protein-circuits-in-the-gastrointestinal-tumour-microenvironment-determinants-of-immunotherapy-response-and-resistance/349654/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/secreted-protein-circuits-in-the-gastrointestinal-tumour-microenvironment-determinants-of-immunotherapy-response-and-resistance/349654.png","ImageObject",300,407,{"name":42,"@type":43},"MrHarris58","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why do gastrointestinal cancers show resistance to immune checkpoint blockade?","Question",{"text":63,"@type":64},"Resistance can occur despite checkpoint blockade because extracellular signalling programmes in the tumour microenvironment shape immune recruitment, access, and suppression. These effects create primary, incomplete, and acquired resistance beyond what tumour-cell genomics alone can explain.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does the tumour secretome play in immunotherapy response?",{"text":68,"@type":64},"The tumour secretome—including cytokines, chemokines, growth factors, complement components, soluble checkpoint molecules, and extracellular-vesicle-associated cargo—regulates immune-cell recruitment, exclusion, suppression, tertiary lymphoid structure formation, and exhaustion.",{"name":70,"@type":61,"acceptedAnswer":71},"How do different secreted protein circuits relate to immune-permissive versus suppressive states?",{"text":72,"@type":64},"Recurrent suppressive circuits include TGF-β, VEGF and several chemokine modules that drive immune exclusion and suppression. In contrast, CXCL9/10/11-CXCR3 signalling and CXCL13-associated tertiary lymphoid structures characterize immune-permissive states that can support checkpoint responsiveness.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349654,1790169448,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Li et al. Journal of Translational Medicine (2026) 24:1185  \n[https://doi.org/10.1186/s12967-026-08945-x](https://doi.org/10.1186/s12967-026-08945-x)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nSecreted protein circuits in the  \ngastrointestinal tumour microenvironment: determinants of immunotherapy response and resistance  \nKexun Li 1,2*†, Zilong Qian2†, Jie Mao3†, Yongtao Han1 and Xuefeng Leng1*  \nAbstract  \nImmune checkpoint blockade has transformed treatment in selected gastrointestinal (GI) cancers, yet primary resistance, incomplete responses and acquired resistance remain common. This heterogeneity is not explained by tumour-cell genomics alone; extracellular signalling programmes within the tumour microenvironment can determine immune recruitment, access and adaptation to therapy. The tumour secretome—including cytokines, chemokines, growth factors, complement components, matricellular proteins, soluble checkpoint molecules and extracellular-vesicle-associated cargo—regulates immune-cell recruitment, exclusion, suppression, tertiary lymphoid structure formation and exhaustion across anatomical and molecular contexts. Across gastric and esophageal cancers, colorectal cancer, pancreatic ductal adenocarcinoma, hepatocellular carcinoma and biliary tract cancers, recurrent suppressive circuits include TGF-β, VEGF, CXCL12-CXCR4, CXCL8/IL-8-CXCR1/2, CCL2-CCR2, CSF1-CSF1R, IL-6-family cytokines, SPP1/osteopontin, periostin, galectins, DKK1, MIF, complement and soluble or vesicular PDL1 . Conversely, CXCL9/10/11-CXCR3 signalling and CXCL13-associated tertiary lymphoid structures characterise immune-permissive states that can support checkpoint responsiveness. We organise these circuits into four overlapping functional modules—myeloid-enriched, fibroblast-driven exclusion, angiogenic-immunosuppressive and immune-permissive—and apply a four-level evidence hierarchy that separates clinical validation from mechanistic inference. Clinically useful secretome biomarkers will therefore need to integrate cellular source, spatial localisation, receptor context, temporal dynamics and linkage to actionable immune-state transitions.  \nHighlights  \n• Secreted proteins constitute a dynamic extracellular layer of the GI tumour microenvironment and can strongly influence immunotherapy response even when genomic biomarkers appear favourable.  \n†Kexun Li, Zilong Qian and Jie Mao contributed equally to this work and share first authorship.  \n*Correspondence: Kexun Li [likexun@yeah.net](likexun@yeah.net)[ ](likexun@yeah.net)Xuefeng Leng [doc.leng@uestc.edu.cn](doc.leng@uestc.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLi et al. Journal of Translational Medicine (2026) 24:1185 Page 2 of 18  \n• Protein abundance alone is insufficient; source, spatial topology, receptor dist","cbCaivjriYrEuOY9","https://ap.wps.com/l/cbCaivjriYrEuOY9","pdf",7553100,18,"English","# Abstract\n## Highlights\n## Introduction","[{\"question\":\"Why do gastrointestinal cancers show resistance to immune checkpoint blockade?\",\"answer\":\"Resistance can occur despite checkpoint blockade because extracellular signalling programmes in the tumour microenvironment shape immune recruitment, access, and suppression. These effects create primary, incomplete, and acquired resistance beyond what tumour-cell genomics alone can explain.\"},{\"question\":\"What role does the tumour secretome play in immunotherapy response?\",\"answer\":\"The tumour secretome—including cytokines, chemokines, growth factors, complement components, soluble checkpoint molecules, and extracellular-vesicle-associated cargo—regulates immune-cell recruitment, exclusion, suppression, tertiary lymphoid structure formation, and exhaustion.\"},{\"question\":\"How do different secreted protein circuits relate to immune-permissive versus suppressive states?\",\"answer\":\"Recurrent suppressive circuits include TGF-β, VEGF and several chemokine modules that drive immune exclusion and suppression. In contrast, CXCL9/10/11-CXCR3 signalling and CXCL13-associated tertiary lymphoid structures characterize immune-permissive states that can support checkpoint responsiveness.\"}]","Secreted protein circuits in the gastrointestinal tumour microenvironment: determinants of immunotherapy response and resistance | PDF",1790084834,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1938a9569537785d3245187f089cd93.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1937c42583c047944a779c4ee28f04b8.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0affca56ba37babd0b6f5a511ca8851.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5708dd2fb5a11d9037cf36284eb73254.webp",980,1306]